Skip to content
Tuesday, December 16, 2025
LibraGen France

LibraGen France

omega-transaminases chiral amines anti-infectious and cancer

  • Corporate overview
  • Distributors
  • Innovative technologies
  • Management
  • Network of partners
  • Research

Research

While focusing the business on the Company’s core skills in biocatalysis and bioprocess technology, LibraGen is investing on high added value proprietary projects in order to ensure mid and long-term creation of value.

Holding key patents on its technology platform and proprietary products, LibraGen is daily combining innovation with industrial know-how.

Share
Facebook Twitter Pinterest Linkedin

Recent Posts

  • Unlocking the Future of Therapeutics: The Role of Next-Generation Antibodies in Affinity Maturation and DNA-Encoded Innovation
  • NGS Meets Antibodies: A New Era in Precision Medicine and Therapy Optimization
  • Navigating Glycan-Protein Interaction Repositories: Advancing Drug Discovery and Breakthroughs
  • Advancements in Glycosylation Pathways: Defining the Future of Biotechnological Production and Therapeutic Development
  • Glycosylation Patterns and Its Influence on mAbs: Improving Therapeutic Potential Through Glycoengineering

Categories

  • Blog
  • Uncategorized
All Rights Reserved 2021.
Proudly powered by WordPress | Theme: Refined Blog by Candid Themes.